FindTrial
Sign In

Establishment and application of non-invasive DNA diagnosis of fetal ABO/RH blood group system

Establishment and application of non-invasive DNA diagnosis of fetal ABO/RH blood group system

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009998
Enrollment
Unknown
Registered
2016-11-24
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemolytic disease of newborn caused by maternal and infant blood group incompatibility

Interventions

Gold Standard:
Index test:

Sponsors

Shanghai Tongji Hosopital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Blood samples of obstetric clinic "type O /RHD negative" pregnant couples for medical testing; Age, nationality, region is not limited.

Exclusion criteria

Exclusion criteria: Blood lipid and hemolysis; Origin is unknown,can not be traced back samples.

Design outcomes

Primary

MeasureTime frame
Blood Genotype Group;—

Countries

China

Contacts

Public ContactZimin Lu

Shanghai Tongji Hosopital

zimin136817@163.com+86 13681718180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026